Phastar And Beaconcure Announce Partnership To Deliver Process Revolution In Clinical Data Review
Beaconcure Inc., a leader in AI-enabled clinical data validation, partners with Phastar Inc., a global specialist biometrics CRO, to enhance clinical review processes in trials. This collaboration integrates Beaconcure's advanced technology with Phastar’s experience in clinical data analytics, aiming to streamline trial development and expedite drug delivery. Ilan Carmeli, Beaconcure’s COO, highlights the collaboration's potential to reduce errors and improve efficiency through the Verify platform, facilitating faster study validation and approvals. Ping-Chung Chang of Phastar emphasizes the importance of addressing critical areas in clinical review, leveraging Verify to enhance data reporting, review, and submission stages, ultimately advancing patient access to lifesaving treatments.
Christine Oliver, Beaconcure’s CEO, underscores the partnership's commitment to innovation and industry standards, aiming to increase speed and compliance in clinical trials. Phastar, with its global presence and expertise, prioritizes timely, quality work, aligning with Beaconcure's mission to transform clinical research through technological advancements. This collaboration signifies a proactive approach to creating dynamic systems that learn and improve over time, benefiting patients, sponsors, and the entire clinical research ecosystem.
Comments
Post a Comment